The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity

L de Lecea

T Kilduff

C Peyron

X Gao

V Gautvik+6 authors

Departments of ^{Molecular Biology and}^{Neuropharmacology, The Scripps Research Institute, La Jolla, CA 92037;}^{Center for Sleep and Circadian Neurobiology, Stanford University, Stanford, CA 94305;}^{Department of Neurosurgery, Yale University, New Haven, CT 06520;}^{Institute of Basic Medical Sciences, Department of Biochemistry, University of Oslo, P.O. Box 1112, Blindern, N-0317 Oslo, Norway; and}^{The Jackson Laboratory, Bar Harbor, ME 04609}

^{L.d.L. and T.S.K. contributed equally to this paper.}

Contributed by F. E. Bloom

Accepted 1997 Nov 17.

Abstract

We describe a hypothalamus-specific mRNA that encodes preprohypocretin, the putative precursor of a pair of peptides that share substantial amino acid identities with the gut hormone secretin. The hypocretin (Hcrt) protein products are restricted to neuronal cell bodies of the dorsal and lateral hypothalamic areas. The fibers of these neurons are widespread throughout the posterior hypothalamus and project to multiple targets in other areas, including brainstem and thalamus. Hcrt immunoreactivity is associated with large granular vesicles at synapses. One of the Hcrt peptides was excitatory when applied to cultured, synaptically coupled hypothalamic neurons, but not hippocampal neurons. These observations suggest that the hypocretins function within the CNS as neurotransmitters.

Abstract

The hypothalamus acts as a major regulatory center for autonomic and endocrine homeostasis. Structurally, it is a confederation of nuclei that regulate a broad array of physiological and behavioral activities. For some of these activities, particular peptides have been identified as major products of individual nuclei (1). These peptides exert their actions by transport to the pituitary, by entering the general circulation, or by secretion within the CNS. However, the hypothalamus has been implicated in the regulation of activities beyond those for which factors have been identified.

We recently used directional tag PCR subtraction to identify 38 rat mRNAs selectively expressed within the hypothalamus (2). Preliminary in situ hybridization studies revealed that one of these, called clone 35 in that work, was expressed exclusively by a bilaterally symmetric structure within the posterior hypothalamus. Here we show that the clone 35 mRNA encodes the precursor of two putative peptides, the hypocretins, that share substantial amino acid identities with each other and with the gut hormone secretin. The Hcrt mRNA, which accumulates primarily after postnatal week 3 and in mouse is a product of a gene on chromosome 11, is restricted to neuronal cell bodies of the dorsal and lateral hypothalamus. Its protein product, visualized immunocytochemically, is sorted into secretory vesicles in fibers that project within the hypothalamus and to other brain areas. At least one of the peptides has neuroexcitatory activity. Cumulatively, these observations suggest that the Hcrt mRNA encodes peptides that act endogenously within the central nervous system as homeostatic regulators. The circuitry revealed by the immunohistochemistry suggests a role in nutritional homeostasis.

Acknowledgments

We thank Laurie McPherson, Devin Tighe and Briant Lee for excellent technical assistance. Supported in part by grants from the National Institutes of Health (GM32355, NS33396, AG11084), Air Force Office of Scientific Research (F49620-95-1-0247), Army Research Office (DAAH04-95-1-0616), Norwegian Research Council, Fyssen Foundation, and Digital Gene Technologies.

Acknowledgments

ABBREVIATION

Hcrt	hypocretin

ABBREVIATION

Footnotes

Data deposition: The sequences reported in this paper have been deposited in the GenBank database (accession nos. {"type":"entrez-nucleotide","attrs":{"text":"AF019565","term_id":"2895193"}}AF019565 and {"type":"entrez-nucleotide","attrs":{"text":"AF019566","term_id":"2895195"}}AF019566).

Footnotes

References

1. Swanson L W In: Handbook of Chemical Anatomy. Bjorkland A, Hokfelt T, Swanson L W, editors. Vol. 5. New York: Elsevier; 1987. pp. 1–124. [PubMed][Google Scholar]
2. Gautvik K M, de Lecea L, Gautvik V T, Danielson P E, Tranque P, Dopazo A, Bloom F E, Sutcliffe J G. Proc Natl Acad Sci USA. 1996;93:8733–8738.
3. Sutcliffe J G, Milner R J, Shinnick T S, Bloom F E. Cell. 1983;33:671–682.[PubMed]
4. Fehmann H-C, Goke R, Goke B. Endocr Rev. 1995;16:390–410.[PubMed]
5. Eipper B A, Stoffers D A, Mains R E. Annu Rev Neurosci. 1992;15:57–85.[PubMed]
6. de Lecea L, Ruiz-Lozano P, Danielson P E, Peelle-Kirley J, Foye P E, Frankel W N, Sutcliffe J G. Genomics. 1997;42:499–506.[PubMed]
7. Swanson L W Brain Maps: Structure of the Rat Brain. Amsterdam: Elsevier; 1992. [PubMed][Google Scholar]
8. Paxinos G, Watson C The Rat Brain in Stereotaxic Coordinates. Sydney: Academic; 1986. [PubMed][Google Scholar]
9. Segre G V, Goldring S R. Trends Endocrinol Metab. 1993;4:309–314.[PubMed]
10. Bray G A, York D A. Physiol Rev. 1979;59:719–809.[PubMed]
11. Teitelbaum L A, Epstein A N. Psychol Rev. 1960;69:74–90.[PubMed]
12. Grossman S P, Dacey D, Halaris A E, Routenberg A. Science. 1978;202:537–539.[PubMed]
13. Stricker E M, Verbalis J G. Nutr Rev. 1990;48:49–56.[PubMed]
14. Loewy A D, Spyer K M, editors. Central Regulation of Autonomic Functions. New York: Oxford Univ. Press; 1990. [PubMed]
15. Randall W C, editor. Nervous Control of Cardiovascular Function. New York: Oxford Univ. Press; 1984. [PubMed]
16. Berkenbosch F, van Oers J, del Ray A, Tilders F, Besedovsky H. Science. 1987;238:524–526.[PubMed]
17. Cunningham E T, De Souza E B. Immunol Today. 1993;14:171–176.[PubMed]
18. Rivier C. Front Neuroendocrinol. 1995;16:151–182.[PubMed]
19. Morley J E. Endocr Rev. 1987;8:256–287.[PubMed]
20. Clark J T, Kalra P S, Crowley W R, Kalra S P. Endocrinology. 1984;115:427–429.[PubMed]
21. Levine A S, Morley J E. Peptides (Tarrytown, NY) 1984;5:1025–1029.[PubMed]
22. Stanley B G, Leibowitz S F. Life Sci. 1984;35:2635–2642.[PubMed]
23. Kyrkouli S E, Stanley B G, Leibowitz S F. Eur J Pharmacol. 1986;122:159–160.[PubMed]
24. Tempel D L, Leibowitz S F. Brain Res Bull. 1990;25:821–825.[PubMed]
25. Qu D, Ludwig D S, Gammeltoft S, Piper M, Pelleymounter M A, Cullen M J, Mathes W F, Przypek J, Kanarek R, Maratos-Flier E. Nature (London) 1996;380:243–247.[PubMed]
26. Rossi M, Choi S J, O’Shea D, Miyoshi T, Ghatei M A, Bloom S R. Endocrinology. 1997;138:351–355.[PubMed]
27. Smith G P, Gibbs J. Pharmacol Biochem Behav. 1975;3:135–138.[PubMed]
28. Gibbs J, Fauser D J, Rowe E A, Rolls B J, Rolls E T, Madison S P. Nature (London) 1979;282:208–210.[PubMed]
29. Britton D R, Koob G F, Rivier J, Vale W. Life Sci. 1982;31:363–367.[PubMed]
30. Levine A S, Rogers B, Kneip J, Grace M, Morley J E. Neuropharmacology. 1983;22:337–339.[PubMed]
31. Arase K, York D A, Shimizu H, Shargill N, Bray G A. Am J Physiol. 1988;255:E255–E259.[PubMed]
32. Spina M, Merlo-Pich E, Chan R K W, Basso A M, Rivier J, Vale W, Koob G F. Science. 1996;273:1561–1564.[PubMed]
33. Zamir N, Skofitsch G, Jacobowitz D M. Brain Res. 1986;373:240–245.[PubMed]
34. Skofitsch G, Jacobowitz D M, Zamir N. Brain Res Bull. 1985;15:635–649.[PubMed]
35. Naito N, Kawazoe I, Nakai Y, Kawauchi H. Cell Tissue Res. 1988;253:291–295.[PubMed]
36. Bittencourt J C, Presse F, Arias C, Peto C, Vaughan J, Nahon J L, Vale W, Sawchenko P E. J Comp Neurol. 1992;319:218–245.[PubMed]
37. Mountjoy K G, Mortrud M T, Low M J, Simerly R B, Cone R D. Mol Endocrinol. 1994;8:1298–1308.[PubMed]
38. Huszar D, Lynch C A, Fairchild-Huntress V, Dunmore J H, Fang Q, Berkemeier L R, Gu W, Kesterson R A, Boston B A, Cone R D, Smith F J, Campfield L A, Burn P, Lee F. Cell. 1997;88:131–141.[PubMed]
39. Ollmann M M, Wilson B D, Yang Y K, Kerns J A, Chen Y, Gantz I, Barsh G S. Science. 1997;278:135–138.[PubMed]
40. de Lecea L, Soriano E, Criado J R, Steffensen S C, Henriksen S J, Sutcliffe J G. Brain Res Mol Brain Res. 1994;25:286–296.[PubMed]